[1]朱光宇,滕皋军,郭金和,等.联合应用沙培林碘化油乳剂及促凝血药物治疗肝脏恶性肿瘤[J].介入放射学杂志,2007,(01):24.
　ZHU Guang-yu,TENG Gao-jun,GUO Jin-he,et al.Combined application of sapyrin-lipiodol emulsion and blood coagulant in treatment of liver malignant tumor[J].journal interventional radiology,2007,(01):24.
点击复制

联合应用沙培林碘化油乳剂及促凝血药物治疗肝脏恶性肿瘤()

PDF下载中关闭

分享到：

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
期数:
2007年01期
页码:
24
栏目:
肿瘤介入
出版日期:
2007-01-15

文章信息/Info

Title:
Combined application of sapyrin-lipiodol emulsion and blood coagulant in treatment of liver malignant tumor
作者:
朱光宇; 滕皋军; 郭金和; 等
２１０００９南京东南大学附属中大医院放射科（朱光宇、滕皋军、郭金和、邓钢、何仕诚、方文），病理科（魏晓莹）
Author(s):
ZHU Guang-yu; TENG Gao-jun; GUO Jin-he; WEI Xiao-ying; DENG Gang; HE Shi-cheng; FANG Wen
Department of Radiology，Zhongda Hospital，Southeast University，Nanjing２１０００９，China
关键词:
肝肿瘤; 沙培林; 介入放射学
分类号:
R７３５.７
文献标志码:
A
摘要:
目的评价联合应用沙培林碘化油乳剂及促凝血药物治疗肝脏恶性肿瘤的疗效。方法联合应用沙培林碘化油乳剂及促凝血药物行免疫栓塞治疗５０例肝脏恶性肿瘤患者，其中原发性肝癌１８例、转移性肝癌３２例。对比治疗前后外周血白细胞、CD ４＋ 、CD ８＋ 淋巴细胞、CD ４＋ ／CD ８＋ 比值、AFP、CEA水平及影像学指标。结果免疫栓塞术后患者CD ４＋ 淋巴细胞比例明显升高，CD ８＋ 淋巴细胞比例基本同术前，外周血白细胞计数升高，CD ４＋ ／CD ８＋ 比值下降，术前AFP及CEA水平升高而术后下降者分别为８６％（１３／１５）和８７％（２１／２４）。发热为最常见的术后不良反应１００％（５０／５０）。结论联合应用沙培林碘化油乳剂及促凝血药物治疗肝脏恶性肿瘤是一种安全有效的方法，对原发性肝癌与转移性肝癌均有较好的疗效，是一种更趋标准化的免疫栓塞方法。

参考文献/References:

［１］Cha C，DeMatteo RP，Blumgart LH．Surgery and ablative the-rapy for hepatocellular carcinoma［J］．J Clin Gastroenterol，２００２，３５：S１３０-S１３７
［２］Sturm JW，Keese MA，Bonninghoff RG，et al．Locally ablative therapies of hepatocellular carcinoma［J］．Onkologie，２００１，Suppl５：３５-４５．
［３］Chen J，Chen M，Christoph R，et al．Molecular therapy of ga-stric cancer［J］．Cancer Ther，２００３，１：３２３-３３３．
［４］Shinichiro I，Setsu M，Chie K，et al．Combination chemoim-munotherapy of murine solid tumor with OK-４３２，G-CSF，IL-２，and chemotherapeutics［J］．Int J Immunopharm，１９９５，１７：９７３-９８０．
［５］汤钊猷，余业勤．原发性肝癌［M］．第二版．上海：上海科学技术出版社，１９９９．
［６］石田名雄香，晃野孝．诱白性磷球制剂OK-４３２用于癌的免疫治疗［J］．陈仁译．国外医学·免疫学分册，１９８５，８：２９８．
［７］吴建卫，陈汉，吴孟超．瘤体内注射OK-４３２和白细胞介素２治疗原发性肝癌［J］．中华医学杂志，１９９６，７６：３１０-３１１．
［８］Takahashi K，Harauchi D，Kimura S，et al．OK-４３２develops CTL and LAK activity in mononuclear cells from regional lymph nodes of lung cancer patients［J］．Int J Immunopharm，１９９８，２０：３７５-３８８．
［９］Tomioka M，Iinuma H，Okinaga K．Impaired Kupffer cell fun-ction and effect of immunotherapy in obstructive jaundice［J］．J Surg Res，２０００，９２：２７６-２８２．
［１０］Uehara K，Ichida T，Sugahara S，et al．Systemic administration of liposomeencapsulated OK-４３２prolongs the survival of rats with hepatocellular carcinoma through the induction of IFN-gamma-producing hepatic lymphocytes［J］．J Gastroenterol Hepatol，２００２，１７：８１-９０．
［１１］Llovet JM，Real MI，Montana X，et al．Arterial embolization or chemoembolization versus symptomatic treatment in patients with unresectable hepatocellular carcinoma：a randomized controlled trial［J］．Lancet，２００２，３５９：１７３４-１７３９．
［１２］Qian J，Feng GS，Vogl T．Combined interventional therapies of hepatocellular carcinoma［J］．World J Gastroenterol，２００３，９：１８８５-１８９１．
［１３］Kanai T，Moden M，Sakon M，et al．New development of tran-sarterial immuno-embolization（TIE）for therapy of hepato-cellular carcinoma with intrahepatic matastases［J］．Cancer Chemother Pharmacol，１９９４，３３：S４８-S５４．
［１４］Yoshida T，Sakon M，Umeshita K，et al．Appraisal of trans-arterial immunoembolization for hepatocellular carcinoma：a clinic opathologic study［J］．J Clin Gastroenterol，２００１，３２：５９-６５．

相似文献/References:

[1]孟祥文,李芮宗,马自新,等.同轴导管法在肝癌动脉栓塞中的应用[J].介入放射学杂志,1993,(01):16.
[2]李茂全,颜志平,周康荣,等.中晚期肝癌根治术后介入放射学治疗的临床研究[J].介入放射学杂志,1994,(02):79.
[3]程洁敏,王小林,王建华,等.CT片与电视透视相结合行肝穿刺活检[J].介入放射学杂志,1996,(01):20.
[4]罗正益,李兴跃.肝脏疾病的血管造影诊断[J].介入放射学杂志,1996,(01):26.
[5]罗正益,曾炳生,郝春志,等.小肝癌CT和血管造影诊断——自内向外顺序染色征象的意义[J].介入放射学杂志,1996,(01):30.
[6]许永华 朱彤 赵妙嘉 席俊文 张建萍 梁风英.集束电极射频治疗肝恶性肿瘤疗效和并发症的CT评价[J].介入放射学杂志,2002,(01):37.
[7]陈晟,邓钢,牛焕章,等.兔VX２肝种植肿瘤模型制作的完善及综合影像学评价[J].介入放射学杂志,2007,(01):48.
　CHEN Sheng,DENG Gang,NIU Huan-zhang,et al.Consummation in making rabbit model bearing VX２liver tumor and multiple imaging evaluation[J].journal interventional radiology,2007,(01):48.
[8]刘清欣,王建华,罗剑钧,等.肝癌致下腔静脉梗阻的内支架治疗[J].介入放射学杂志,2007,(03):168.
　LIU Qing-xin,WANG Jian-hua,LUO Jian-jun,et al.Stenting in malignant obstruction of inferior vena cava caused by hepatic carcinoma[J].journal interventional radiology,2007,(01):168.
[9]罗剑钧,王建华,刘清欣,等.微球联合碘油栓塞治疗肝癌的初步经验[J].介入放射学杂志,2007,(03):162.
　LUO Jian-jun,WANG Jian-hua,LIU Qing-xin,et al.Preliminary experience of HCC treated by embolization of microspheres combined with lipiodol[J].journal interventional radiology,2007,(01):162.
[10]刘嵘,王建华,颜志平,等.原发性肝癌综合介入治疗后存活５年以上５６例患者临床分析[J].介入放射学杂志,2007,(03):155.
　LIU Rong,WANG Jian-hua,YAN Zhi-ping,et al.Clinical analysis of５６cases of primary liver cancer of over５years survival after comprehensive interventional therapy[J].journal interventional radiology,2007,(01):155.

备注/Memo

备注/Memo:
收稿日期：２００５-０９-２０
更新日期/Last Update: 2007-01-15